HomeELTP • OTCMKTS
Elite Pharmaceuticals, Inc. Common Stock
Follow
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 32.00M | 78.26% |
Operating expense | 4.54M | 3.38% |
Net income | 17.00M | 411.08% |
Net profit margin | 53.12 | 186.67% |
Earnings per share | — | — |
EBITDA | 13.17M | 221.42% |
Effective tax rate | 11.80% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.32M | 59.23% |
Total assets | 96.39M | 15.22% |
Total liabilities | 42.87M | 64.45% |
Total equity | 53.52M | — |
Shares outstanding | 1.07B | — |
Price to book | 11.37 | — |
Return on assets | 34.08% | — |
Return on capital | 56.92% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 17.00M | 411.08% |
Cash from operations | 3.92M | 86.62% |
Cash from investing | -754.11K | -86.82% |
Cash from financing | -137.04K | 65.82% |
Net change in cash | 3.03M | 133.76% |
Free cash flow | -1.80M | -395.30% |
Previous close
$0.57
Day range
$0.55 - $0.58
Year range
$0.16 - $0.82
Market cap
597.81M USD
Avg Volume
2.47M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
About
Founded
1997
Headquarters
Website
Employees
68
